Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The goal of this study is to evaluate how epratuzumab is processed by the body (pharmacokinetics) and whether 2 dose levels of epratuzumab are safe and effective in patients with SLE.
Epistemonikos ID: 70ab1457b112f2285faa6879cd4c8b335fad7653
First added on: May 04, 2024